• roche logo
  • Laboratorian men in the lab

    cobas® HPV Test

    Risk matters. Deliver 3 results in 1 test for accuracy that your clinical partners expect and that patients deserve      

Estimate a patient’s risk for ≥CIN2 

 

Test results can be confusing, but risk is something your patients will understand. Estimate your patient’s risk for cervical disease with the ATHENA patient risk estimator tool*, which incorporates patient age, cytology result, and HPV genotype result to provide an estimate of cervical precancer/cancer risk based on the data from the 47,000 patient ATHENA study.

 

*This patient risk estimator tool is for informational and educational purposes only and is not a medical diagnosis or substitute for the professional judgment of the healthcare professional in diagnosing and treating patients. This patient risk estimator tool is based on the ATHENA trial results and is not intended to represent individual patient results. The information provided should be assessed in the context of the entire patient history.

 


  • Acronyms: